MeiraGTx Holdings plc Increase (Decrease) in Contract with Customer, Asset
MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Contract with Customer, Asset of -$986.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2026-08-13
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for the quarter ending 2025-12-31 was $0.00.
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for the quarter ending 2025-09-30 was $0.00.
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for the quarter ending 2025-06-30 was -$285.00K.
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for the quarter ending 2025-03-31 was -$701.00K.
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for fiscal 2025 was -$986.00K, a 203.35% decline from fiscal 2024.
- MeiraGTx Holdings plc increase (decrease) in contract with customer, asset for fiscal 2024 was $954.00K.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | -$285.00K derived: sum of 3 quarters · filed 2026-08-13 | -$986.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$285.00K derived: sum of 2 quarters · filed 2026-08-13 | -$986.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$986.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$701.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $954.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |